1.Barbagallo, M & Dominguez, LJ (2007) Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys 458, 40–47.
2.Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 3143–3421.
3.Alberti, K, Eckel, RH, Grundy, SM et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640–1645.
4.Azizi, F, Salehi, P, Etemadi, A et al. (2003) Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 61, 29–37.
5.Saris, NE, Mervaala, E, Karppanen, H et al. (2000) Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta 294, 1–26.
6.Salmeron, J, Ascherio, A, Rimm, EB et al. (1997) Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 20, 545–550.
7.Ascherio, A, Rimm, EB, Giovannucci, EL et al. (1992) A prospective study of nutritional factors and hypertension among US men. Circulation 86, 1475–1484.
8.Ascherio, A, Hennekens, C, Willett, WC et al. (1996) Prospective study of nutritional factors, blood pressure, and hypertension among US women. Hypertension 27, 1065–1072.
9.Abbott, RD, Ando, F, Masaki, KH et al. (2003) Dietary magnesium intake and the future risk of coronary heart disease (the Honolulu Heart Program). Am J Cardiol 92, 665–669.
10.Al-Delaimy, WK, Rimm, EB, Willett, WC et al. (2004) Magnesium intake and risk of coronary heart disease among men. J Am Coll Nutr 23, 63–70.
11.Song, Y, Manson, JE, Buring, JE et al. (2004) Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care 27, 59–65.
12.Altura, BM & Altura, BT (1995) Magnesium and cardiovascular biology: an important link between cardiovascular risk factors and atherogenesis. Cell Mol Biol Res 41, 347–359.
13.Rasmussen, HS, Aurup, P, Goldstein, K et al. (1989) Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease. A double-blind, placebo controlled study. Arch Intern Med 149, 1050–1053.
14.He, K, Liu, K, Daviglus, ML et al. (2006) Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 113, 1675–1682.
15.McKeown, NM, Jacques, PF, Zhang, XL et al. (2008) Dietary magnesium intake is related to metabolic syndrome in older Americans. Eur J Nutr 47, 210–216.
16.Sonnenberg, L, Pencina, M, Kimokoti, R et al. (2005) Dietary patterns and the metabolic syndrome in obese and non-obese Framingham women. Obes Res 13, 153–162.
17.van Dam, RM, Hu, FB, Rosenberg, L et al. (2006) Dietary calcium and magnesium, major food sources, and risk of type 2 diabetes in US black women. Diabetes Care 29, 2238–2243.
18.Ghassemi, H, Harrison, G & Mohammad, K (2002) An accelerated nutrition transition in Iran. Public Health Nutr 5, 149–155.
19.Azizi, F, Rahmani, M, Emami, H et al. (2002) Cardiovascular risk factors in an Iranian urban population: Tehran Lipid and Glucose Study (phase 1). Soz Praventivmed 47, 408–426.
20.Hosseini-Esfahani, F, Jessri, M, Mirmiran, P et al. (2010) Adherence to dietary recommendations and risk of metabolic syndrome: Tehran Lipid and Glucose Study. Metabolism 59, 1833–1842.
21.Kriska, AM, Knowler, WC, LaPorte, RE et al. (1990) Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care 13, 401–411.
22.Ainsworth, BE, Haskell, WL, Whitt, MC et al. (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32, 9 Suppl., S498–S504.
23.Mirmiran, P, Esfahani, FH, Mehrabi, Y et al. (2009) Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr 13, 654–662.
24.Ghaffarpour, M, Houshiar-Rad, A & Kianfar, H (1999) The Manual for Household Measures, Cooking Yields Factors and Edible Portion of Food. Tehran: Keshaverzi Press.
25.Azar, MSE (1980) Food Composition Table of Iran. Tehran: National Nutrition and Food Research Institute, Shahid Beheshti University.
27.Azizi, F, Ghanbarian, A, Madjid, M et al. (2002) Distribution of blood pressure and prevalence of hypertension in Tehran adult population: Tehran Lipid and Glucose Study (TLGS), 1999–2000. J Hum Hypertens 16, 305–312.
28.Azizi, F, Ghanbarian, A, Momenan, AA et al. (2009) Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 10, 5.
29.Azizi, F, Hadaegh, F, Khalili, D et al. (2010) Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity. Arch Iran Med 13, 426–428.
30.Franks, PW, Ekelund, U, Brage, S et al. (2004) Does the association of habitual physical activity with the metabolic syndrome differ by level of cardiorespiratory fitness? Diabetes Care 27, 1187–1193.
31.Ford, ES, Li, C, McGuire, LC et al. (2007) Intake of dietary magnesium and the prevalence of the metabolic syndrome among US adults. Obesity (Silver Spring) 15, 1139–1146.
32.Bo, S, Durazzo, M, Guidi, S et al. (2006) Dietary magnesium and fiber intakes and inflammatory and metabolic indicators in middle-aged subjects from a population-based cohort. Am J Clin Nutr 84, 1062–1069.
33.Song, Y, Li, TY, van Dam, RM et al. (2007) Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr 85, 1068–1074.
34.Yokota, K, Kato, M, Lister, F et al. (2004) Clinical efficacy of magnesium supplementation in patients with type 2 diabetes. J Am Coll Nutr 23, issue 5, 506S–509S.
35.Paolisso, G, Sgambato, S, Pizza, G et al. (1989) Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects. Diabetes Care 12, 265–269.
36.de Valk, HW (1999) Magnesium in diabetes mellitus. Neth J Med 54, 139–146.
37.Ma, J, Folsom, AR, Melnick, SL et al. (1995) Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol 48, 927–940.
38.Itoh, K, Kawasaka, T & Nakamura, M (1997) The effects of high oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects. Br J Nutr 78, 737–750.
39.Guerrero-Romero, F & Rodriguez-Moran, M (2002) Low serum magnesium levels and metabolic syndrome. Acta Diabetol 39, 209–213.
40.Rayssiguier, Y, Noe, L, Etienne, J et al. (1991) Effect of magnesium deficiency on post-heparin lipase activity and tissue lipoprotein lipase in the rat. Lipids 26, 182–186.
41.Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285, 2486–2497.
42.Corica, F, Corsonello, A, Ientile, R et al. (2006) Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. J Am Coll Nutr 25, 210–215.
43.Drenick, EJ (1961) The influence of ingestion of calcium and other soap-forming substances on fecal fat. Gastroenterology 41, 242–244.
44.Liu, S, Willett, WC, Manson, JE et al. (2003) Relation between changes in intakes of dietary fiber and grain products and changes in weight and development of obesity among middle-aged women. Am J Clin Nutr 78, 920–927.
45.O'Byrne, DJ, Knauft, DA & Shireman, RB (1997) Low fat-monounsaturated rich diets containing high-oleic peanuts improve serum lipoprotein profiles. Lipids 32, 687–695.
46.Slavin, JL, Martini, MC, Jacobs, DR Jr et al. (1999) Plausible mechanisms for the protectiveness of whole grains. Am J Clin Nutr 70, 3 Suppl., 459S–463S.
47.Halliwell, B (2000) The antioxidant paradox. Lancet 355, 1179–1180.
48.Kao, WH, Folsom, AR, Nieto, FJ et al. (1999) Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Intern Med 159, 2151–2159.